The Neuro-Patient Resource has created reading lists for each of the Neuro's outpatient clinics. Come borrow the books in room 354!
Download the PDF version of a reading list below:
Come visit us and borrow the books below today from room 354 at The Neuro:
-
Être du monde by Maryse Rouy
-
Voir la mer by Ruth Fitzmaurice
-
Epilepsies de l'enfant, de l'adolescent et de l'adulte : de la physiopathologie à la prise en charge by Sophie Dupont
-
Les Épilepsies N. éd. by Nathalie Tordjman
-
Épilepsie et psychiatrie by Pierre Thomas & Arnaud Biraben
-
L'Après-cancer : tout un programme ! by Philippe Gourdin & Gersande Bargine
Category:
Published on: 28 Sep 2023
We selected books from our collection to highlight Stroke Awareness Month and ALS Awareness Month, both happening in June.
We also have free resources that you can get at the Neuro-Patient Resource Centre (room 354).
In addition, our website contains information that is freely accessible:
Our online stroke resources: Stroke (Cerebrovascular accident)
Category:
Published on: 20 Jun 2023
Maria Gobbo is the latest recipient of the ALS fellowship named in his honour
In 2010, former Montreal Alouette and McGill physical education instructor Tony Proudfoot passed away from ALS. Ten years later, his legacy lives on in a fund that helps train and support the next generation of leaders fighting this disease.
Category:
Published on: 28 Jun 2021
Program brings together multidisciplinary teams with expertise in various areas of neurodegenerative disease
Researchers at The Neuro (Montreal Neurological Institute-Hospital) make up a large part of eight projects funded by ALS Canada and the Brain Canada Foundation as part of their 2020 Discovery Grant Program, which brings together multidisciplinary research teams with expertise in various areas of ALS and neurodegenerative diseases to investigate critical areas of disease processes and clinical care.
Category:
Published on: 15 Feb 2021
Scientists demonstrate flaws in protein detection tools, and outline a solution
A new study points to the need for better antibody validation, and outlines a process that other labs can use to make sure the antibodies they work with function properly.
Antibodies are used in laboratories and clinics to study proteins, which are the biomolecules that translate information from an organism’s genes into the structure, function, and regulation of its tissues and organs. Genetic mutations can cause protein imbalances or malfunctions, leading to human disease.
Category:
Published on: 15 Oct 2019
Montreal, Thursday, November 8, 2018 – With the financial support of L’Appui national pour les proches aidants d’aînés and the collaboration of McGill University’s Steinberg Centre for Simulation and Interactive Learning (SCSIL), the Amyotrophic Lateral Sclerosis (ALS) Society of Quebec is proud to launch a virtual education program Taking Care, intended for those caring for someone living with ALS.
On-demand virtual support
Category:
Published on: 8 Nov 2018
Industry and academia to share expertise in effort to develop improved methods to produce and characterize antibodies and reagents for neurological research
Category:
Published on: 5 Mar 2018
Industry and academia team up for the benefit of people suffering from ALS
A unique industry-academia partnership will increase the rate at which promising drug compounds can be tested as potential treatments for amyotrophic lateral sclerosis (ALS), a disease with no known cure that affects 200,000 people worldwide.
The partnership between The Montreal Neurological Institute and Hospital (MNI) and Takeda Pharmaceutical Company Limited (Takeda) will allow compounds developed by Takeda scientists to be tested on cell lines produced at the MNI.
Category:
Published on: 4 Dec 2017
Research symposium, public education event and ALS walk planned
Multiple events planned for this week will help educate the public about amyotrophic lateral sclerosis (ALS), a devastating disease that still has no cure.
Category:
Published on: 13 Sep 2017
The Tenaquip Foundation donation will allow for faster drug development, better care for ALS patients
A generous donation by The Tenaquip Foundation will improve the quality of care available to ALS patients at The Neuro, and increase the rate at which researchers can evaluate new ALS drugs.
Category:
Published on: 3 Jul 2017
ALS takes away the patient’s motor functions one at a time, and the progress of finding effective drugs to counter its insidious effects has been slow. June is ALS Month, a good time to update the public on the latest developments in ALS research taking place at The Neuro.
The Montreal Neurological Institute and Hospital (The Neuro) is recognized as a leading Canadian centre for research into amyotrophic lateral sclerosis (ALS) as well as for its care of ALS patients.
Category:
Published on: 2 Jun 2017
CQDM and Brain Canada join forces again in the funding of two new research projects to address unmet needs in brain research
CQDM and Brain Canada are proud to announce the funding of two new multi-disciplinary and multi-institutional research projects under the second edition of their Focus on Brain strategic initiative. The partners will award a total of $3M to two research teams to develop cutting-edge tools, technologies and platforms designed to accelerate the discovery of new drugs for brain and nervous system disorders.
Category:
Published on: 2 Feb 2017
MNI scientists will study stem cells, genetic mutations to develop new treatments
Researchers at the Montreal Neurological Institute of McGill University who are playing key roles in uncovering the mechanisms underlying ALS will share in $3.9 million in research funding, part of $4.5 million announced on Nov. 23 by the ALS Society of Canada in partnership with Brain Canada.
Category:
Published on: 23 Nov 2016
The Neuro is recognized as a major Canadian center for ALS research and patient care. During June, designated ALS Month, The Neuro redoubles its efforts to inform the public and the media about amyotrophic lateral sclerosis (ALS), and urges all to help support ALS research.
Category:
Published on: 13 Jun 2016
Pages
